2026-11-13 13:02
Economic Observation Network On November 13th, Huawei officially announced its first independent blood glucose monitoring product - Huawei Weigan G1 Continuous Glucose Monitoring System. This product is Huawei's first dynamic blood glucose meter to obtain Class III medical device registration certification from the National Medical Products Administration. It supports 24/7 continuous blood glucose monitoring, can view data on multiple devices such as mobile phones and smartwatches, and provides blood glucose abnormality reminders. It can be used for up to 16 days per use, providing users with a continuous and visual blood glucose trend management solution.
Changan Automobile listed for transfer of 10% equity of Avita Technology, with a minimum price of approximately 3.2 billion yuan
The "golden nine and silver ten" in the car market have faded domestically, but exports have surged
Post Friendship Period "has become a hot search and hit the screen, becoming a dark horse in variety shows in 2026
